medigraphic.com
SPANISH

Revista Mexicana de Urología

Organo Oficial de la Sociedad Mexicana de Urología
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2019, Number 6

<< Back

Rev Mex Urol 2019; 79 (6)

Primary melanoma of the penis

Sandoval-Téllez JG, Ricardez-Espinosa AA, Jiménez-López LA, Pardo-Castillo E
Full text How to cite this article

Language: Spanish
References: 25
Page: 1-7
PDF size: 240.37 Kb.


Key words:

Melanoma, Cancer, Penis.

ABSTRACT

Clinical case: A 54-year-old man had an unremarkable past medical history and was evaluated due to lower urinary tract symptoms. He presented with phimosis and a hard lesion was palpated in the glans penis. A dorsal slit of the foreskin was performed, revealing a black, warty tumor of stony-hard consistency. Treatment was total penectomy. There was hepatic, splenic, and left inguinal lymph node tumor progression, as well as blastic lesions at the L4, T7, and T9 levels. Temozolomide was the initial palliative treatment, followed by interferon alpha-2b and zoledronic acid. The patient died 16 months after diagnosis
Relevance: Melanoma of the penis is an aggressive, rapidly progressing, malignant cutaneous neoplasia, with a high mortality rate, that derives from atypical melanocytic proliferation. It accounts for less than 1% of the cases of penile cancer and less than 0.2% of all melanomas. Approximately 200 cases have been reported in the literature.
Clinical implications: Treatment is surgical, through total penectomy, but there is no standardized management. The most reasonable treatment option appears to be radical surgery, when possible, together with adjuvant therapy.
Conclusions: Malignant melanoma of the penis is a cutaneous tumor of poor prognosis, given its great capacity to produce metastases, especially through lymphatic dissemination. Chemotherapy and radiotherapy are only palliative or adjuvant treatments and offer varying results.


REFERENCES

  1. Fuente-García A de la, Ocampo-Candiani J. Melanoma cutáneo. Gac Med Mex. 2010;146(2):126–35.

  2. Sabatini-Ugarte N, Molgó M, Vial G. Melanoma en Chile ¿Cuál es nuestra realidad? Revista Médica Clínica Las Condes. 2018 Jul 1;29(4):468–76. doi: https://doi.org/10.1016/j. rmclc.2018.06.006

  3. Iversen K, Robins RE. Mucosal malignant melanomas. The American Journal of Surgery. 1980 May 1;139(5):660–4. doi: https://doi. org/10.1016/0002-9610(80)90358-X

  4. Stillwell Thomas J., Zincke Horst, Gaffey Thomas A., Woods John E. Malignant Melanoma of the Penis. Journal of Urology. 1988 Jul 1;140(1):72–5. doi: https://doi.org/10.1016/ S0022-5347(17)41490-X

  5. Cold CJ, Taylor JR. The prepuce. BJU International. 1999;83(S1):34–44. doi: https:// doi.org/10.1046/j.1464-410x.1999.0830s1034.x

  6. Seetharamu N, Ott PA, Pavlick AC. Mucosal melanomas: a case-based review of the literature. Oncologist. 2010;15(7):772–81. doi: https:// doi.org/10.1634/theoncologist.2010-0067

  7. Te CC, Vemulapalli S, Confer SD, Culkin DJ. Recurrent Malignant Melanoma of the Penis. Urology. 2008 Nov 1;72(5):1185.e15- 1185.e16. doi: https://doi.org/10.1016/j. urology.2008.01.029

  8. Gross S. A System of Surgery. 6th ed. Philadelphia: W.B.Saunders; 1882.

  9. Herrera González NE, Flores AYA. Melanoma in Mexico. Rev Esp Med Quir. 2010;15(3):161–4.

  10. Parada RJ, Pineda B, León G. Melanoma maligno cutáneo. Perfil epidemiológico en México. Gac Med Oncol. 2003;2(2):17–22.

  11. Frías Ancona G, Hidalgo CO, Hernández MEL. Estudio epidemiológico de melanoma maligno en el American British Cowdray Medical Center. Anales Médicos de la Asociación Médica del Centro Médico ABC. 2011;56(4):196–204.

  12. Kim CJ, Pak K, Hamaguchi A, Ishida A, Arai Y, Konishi T, et al. Primary malignant melanoma of the female urethra. Cancer. 1993;71(2):448– 51. doi: https://doi.org/10.1002/1097- 0142( 19930115 ) 71: 2% 3C 448: : AID-CNCR2820710227%3E3.0.CO;2-Y

  13. Papeš D, Altarac S, Arslani N, Rajković Z, Antabak A, Ćaćić M. Melanoma of the glans penis and urethra. Urology. 2014;83(1):6–11. doi: https://doi.org/10.1016/j.urology.2013.07.009

  14. Demitsu T, Nagato H, Nishimaki K, Okada O, Kubota T, Yoneda K, et al. Melanoma in situ of the penis. Journal of the American Academy of Dermatology. 2000 Feb 1;42(2, Part 2):386–8. doi: https://doi.org/10.1016/S0190- 9622(00)90120-8

  15. Turnbull N, Shim T, Patel N, Mazzon S, Bunker C. Primary Melanoma of the Penis in 3 Patients With Lichen Sclerosus. JAMA Dermatol. 2016 Feb 1;152(2):226–7. doi: http://dx.doi. org/10.1001/jamadermatol.2015.3404

  16. van Geel AN, den Bakker MA, Kirkels W, Horenblas S, Kroon BBR, de Wilt JHW, et al. Prognosis of primary mucosal penile melanoma: a series of 19 Dutch patients and 47 patients from the literature. Urology. 2007 Jul;70(1):143–7. doi: https://doi.org/10.1016/j. urology.2007.03.039

  17. Carli P, Giorgi VD, Soyer H, Stante M, Mannone F, Giannotti B. Dermatoscopy in the diagnosis of pigmented skin lesions: a new semiology for the dermatologist. Journal of the European Academy of Dermatology and Venereology. 2000;14(5):353–69. doi: https:// doi.org/10.1046/j.1468-3083.2000.00122.x

  18. Gajdos C, Griffith KA, Wong SL, Johnson TM, Chang AE, Cimmino VM, et al. Is there a benefit to sentinel lymph node biopsy in patients with T4 melanoma? Cancer. 2009;115(24):5752–60. doi: https://doi.org/10.1002/cncr.24660

  19. Viveros EJM, Montor JGM, Moscoso IE, Ferro FC. Melanoma de pene. Presentación de un caso y revisión de la literatura. Rev Mex Urol. 2005;65(4):277–80.

  20. Bracken RB, Diokno AC. Melanoma of the penis and the urethra: 2 case reports and review of the literature. J Urol. 1974 Feb;111(2):198– 200. doi: https://doi.org/10.1016/s0022- 5347(17)59926-7

  21. Sánchez-Ortiz Ricardo, Huang Samuel F., Tamboli Pheroze, Prieto Victor G., Hester Greg, Pettaway Curtis A. Melanoma of the penis, scrotum and male urethra: a 40-year single institution experience. Journal of Urology. 2005 Jun 1;173(6):1958–65. doi: https://doi. org/10.1097/01.ju.0000159207.91737.53

  22. Bechara GR, Schwindt AB de S, Ornellas AA, Silva DEA da, Lott FM, Campos FS de, et al. Penile primary melanoma: analysis of 6 patients treated at Brazilian national cancer institute in the last eight years. International braz j urol. 2013 Dec;39(6):823–31. doi: http://dx.doi. org/10.1590/S1677-5538.IBJU.2013.06.08

  23. Finn L, Markovic SN, Joseph RW. Therapy for metastatic melanoma: the past, present, and future. BMC Medicine. 2012 Mar 2;10(1):23. doi: https://doi.org/10.1186/1741-7015-10-23

  24. Tsao H, Atkins MB, Sober AJ. Management of Cutaneous Melanoma. New England Journal of Medicine. 2004 Sep 2;351(10):998–1012. doi: https://doi.org/10.1056/NEJMra041245

  25. Johnson Michael H., Brandes Steven B., Humphrey Peter A. Recurrent and Metastatic Malignant Melanoma of the Penis. Journal of Urology. 2012 Apr 1;187(4):1438–9. doi: https://doi.org/10.1016/j.juro.2012.01.024




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Mex Urol. 2019;79